Metformin turns off the metabolic switch of pancreatic cancer

por Deschênes-Simard, Xavier, Rowell, Marie-Camille, Ferbeyre, Gerardo
Publicado 2019

Phenylethynylbenzyl-modified biguanides inhibit pancreatic cancer tumor growth

por Hébert, Audrey, Parisotto, Maxime, Rowell, Marie-Camille, Doré, Alexandra, Fernandez Ruiz, Ana, Lefrançois, Guillaume, Kalegari, Paloma, Ferbeyre, Gerardo, Schmitzer, Andreea R.
Publicado 2021

The NAMPT Inhibitor FK866 Increases Metformin Sensitivity in Pancreatic Cancer Cells

por Parisotto, Maxime, Vuong-Robillard, Nhung, Kalegari, Paloma, Meharwade, Thulaj, Joumier, Loick, Igelmann, Sebastian, Bourdeau, Véronique, Rowell, Marie-Camille, Pollak, Michael, Malleshaiah, Mohan, Schmitzer, Andréea, Ferbeyre, Gerardo
Publicado 2022

Circumventing senescence is associated with stem cell properties and metformin sensitivity

por Deschênes‐Simard, Xavier, Parisotto, Maxime, Rowell, Marie‐Camille, Le Calvé, Benjamin, Igelmann, Sebastian, Moineau‐Vallée, Karine, Saint‐Germain, Emmanuelle, Kalegari, Paloma, Bourdeau, Véronique, Kottakis, Filippos, Bardeesy, Nabeel, Ferbeyre, Gerardo
Publicado 2019